80139-91-9

Basic information

• Product Name: Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride)
• Synonyms: Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride);Levocabastine Related CoMpound A;Desmethyl rac-Cabastine Hydrochloride
• CAS NO: 80139-91-9
• Molecular Formula: C25H28ClFN2O2
• Molecular Weight: 442.9534232
• Mol File: 80139-91-9.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride)(CAS DataBase Reference)
• NIST Chemistry Reference: Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride)(80139-91-9)
• EPA Substance Registry System: Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride)(80139-91-9)

Safety Data

• Hazardous Substances Data: 80139-91-9(Hazardous Substances Data)

Usage

Description

Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride) is a chemical compound derived from Cabastine, a histamine H1 receptor antagonist used in the treatment of allergic conjunctivitis. It is characterized by its unique molecular structure, which includes a cis-4-cyano-4-(4-fluorophenyl)cyclohexyl group and a 4-phenylpiperidine-4-carboxylic acid moiety, with a hydrochloride salt form.

Uses

Used in Pharmaceutical Industry:
Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride) is used as an intermediate in the synthesis of pharmaceuticals, specifically for the development of drugs targeting histamine H1 receptors. Its unique structure allows for the exploration of new therapeutic agents with improved efficacy and reduced side effects in the treatment of allergic conditions.
Used in Research and Development:
Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride) serves as a valuable research tool in the study of histamine H1 receptor antagonists and their potential applications in various allergic diseases. It can be utilized in experimental settings to investigate the structure-activity relationship, pharmacokinetics, and pharmacodynamics of novel compounds with potential therapeutic benefits.
Used in Quality Control and Standardization:
As a USP Related Compound, Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride) plays a crucial role in ensuring the quality, purity, and consistency of pharmaceutical products containing histamine H1 receptor antagonists. It can be employed as a reference standard in analytical methods, such as high-performance liquid chromatography (HPLC) and mass spectrometry, to validate the identity, potency, and purity of active pharmaceutical ingredients.